ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans

Duke University at ASHI 2026

Oct 26–30, 2026 Montréal, Canada ~1k attendees Website

Duke University takes part in 5 sessions at ASHI 2026 in Montréal. Its program focuses on desensitizing highly sensitized kidney transplant candidates, including how carfilzomib plus belatacept affects HLA and anti-microbial antibodies and which antibodies respond. It also covers case-based views of antibody-mediated rejection and the path from HLA discovery to precision medicine.

OrganizationASHI 2026 Attendance
Duke University
Durham, NC
Universities & research institutes
Private research university with a school of medicine and the Duke University Health System, which runs organ and stem cell transplant programs.
Talk
Thu Oct 29
8:45am–9:30am
HLA Discovery to Precision Medicine: The journey is not over
HLA typing, sequencing and genotyping
Session
Thu Oct 29
1:10pm–2:40pm
Workshop 4: Beyond the Paradigm: Case-Based Insights into the Spectrum of Antibody-Mediated Rejection in Kidney Transplantation
517A
with KU Leuven, Northwestern University, KSL Diagnostics
Solid organ transplantationHLA antibodies, crossmatching and eplets

Explore the full ASHI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Duke University

Tell us what you sell and we’ll find the people at Duke University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction